Investor relations
Bio-Works Technologies rights issue oversubscribed
Bio-Works Technologies AB (“Bio-Works” or the “Company”) has completed the rights issue of units approved at the extraordinary general meeting on July 29, 2024 (the “Rights Issue”). The outcome shows that 36 525 888 units, corresponding to approximately 93.7 percent of the Rights Issue, have been subscribed for with unit rights. In addition, a total of 17 733 821 units have been applied for subscription without unit rights, corresponding to approximately 45.5 percent of the Rights Issue. The total subscription rate thus amounts to approximately 139.2 percent of the Rights Issue. The Rights Issue is thus oversubscribed and Bio-Works will receive approximately SEK 39 million through the Rights Issue before deduction of the issue costs.
Annual Report 2023
Bio-Works' 2023 Annual Report describes the company's continued journey as it positions itself as the industry's preferred "tailor" of customized solutions, while implementing significant internal changes with the aim of creating an even more agile and focused organization that is adapted to prevailing market conditions.
4 Reasons to invest in Bio-Works
Latest press release (in Swedish)
Bio-Works Technologies bekräftar produktionsorder värd 2,7 mSEK till ledande CDMO i Sverige
Latest financial reports (in Swedish)
Financial calendar
Get the latest
Contact - Investor relations
Investor relations
Arne Hauge
Stock Information
Bio-Works’ stock is listed on the Spotlight Stock Market where it is traded under the ticker BIOWKS. The ISIN code for the stock is SE0007387089.
See the current price for Bio-Works' (BIOWKS) on the Spotlight Stock Market.